ES2179072T3 - Metodo y composicion para el tratamiento de la osteoporosis. - Google Patents

Metodo y composicion para el tratamiento de la osteoporosis.

Info

Publication number
ES2179072T3
ES2179072T3 ES94912337T ES94912337T ES2179072T3 ES 2179072 T3 ES2179072 T3 ES 2179072T3 ES 94912337 T ES94912337 T ES 94912337T ES 94912337 T ES94912337 T ES 94912337T ES 2179072 T3 ES2179072 T3 ES 2179072T3
Authority
ES
Spain
Prior art keywords
osteoporosis
bicarbonate
treatment
composition
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94912337T
Other languages
English (en)
Inventor
R Curtis Morris Jr
Anthony Sebastian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California, San Diego
Original Assignee
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California, San Diego filed Critical University of California Berkeley
Application granted granted Critical
Publication of ES2179072T3 publication Critical patent/ES2179072T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA COMBINACION DE LOS SIGUIENTES INGREDIENTES ACTIVOS PARA EL TRATAMIENTO DE LA OSTEOPOROSIS: (A) UNA SAL DE POTASIO ALCALINIZADORA FARMACOLOGICAMENTE ACEPTABLE QUE PRODUCE IONES DE HIDROXILO Y POR TANTO ES CAPAZ DE REDUCIR LA ACIDEZ DE LOS FLUIDOS DE LOS TEJIDOS O DE LA ORINA Y QUE SE SELECCIONA DEL GRUPO QUE CONSISTE EN BICARBONATO DE POTASIO Y SALES DE POTASIO DE ACIDOS CARBOXILICOS QUE SE TRANSFORMAN EN BICARBONATO Y POR TANTO ALCALINIZAN IN VIVO; Y (B) UN DIURETICO DE TIAZIDA.
ES94912337T 1993-04-02 1994-03-29 Metodo y composicion para el tratamiento de la osteoporosis. Expired - Lifetime ES2179072T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4229693A 1993-04-02 1993-04-02

Publications (1)

Publication Number Publication Date
ES2179072T3 true ES2179072T3 (es) 2003-01-16

Family

ID=21921106

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94912337T Expired - Lifetime ES2179072T3 (es) 1993-04-02 1994-03-29 Metodo y composicion para el tratamiento de la osteoporosis.

Country Status (11)

Country Link
EP (1) EP0691814B1 (es)
JP (1) JPH08508503A (es)
KR (1) KR100312045B1 (es)
CN (1) CN1057207C (es)
AT (1) ATE219625T1 (es)
AU (1) AU694112B2 (es)
BR (1) BR9406182A (es)
DE (1) DE69430864T2 (es)
DK (1) DK0691814T3 (es)
ES (1) ES2179072T3 (es)
WO (1) WO1994022312A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101604350B1 (ko) 2013-07-29 2016-03-17 한국생명공학연구원 클로로티아지드를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3241765A1 (de) * 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate

Also Published As

Publication number Publication date
KR960701644A (ko) 1996-03-28
KR100312045B1 (ko) 2002-02-28
EP0691814A1 (en) 1996-01-17
DE69430864T2 (de) 2003-02-13
EP0691814A4 (en) 1998-09-23
JPH08508503A (ja) 1996-09-10
ATE219625T1 (de) 2002-07-15
DK0691814T3 (da) 2002-10-21
EP0691814B1 (en) 2002-06-26
BR9406182A (pt) 1996-02-06
WO1994022312A1 (en) 1994-10-13
AU6494094A (en) 1994-10-24
CN1057207C (zh) 2000-10-11
CN1120304A (zh) 1996-04-10
DE69430864D1 (de) 2002-08-01
AU694112B2 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
BR9610331A (pt) Composições farmacêuticas para distribuição nasal de compostos úteis para o tratamento de osteoporose
PE30891A1 (es) Composiciones y metodos terapeuticos sinergicos
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
DE69431071D1 (de) Zusammensetzung für lokale freigabe von zytostatika
AR020618A1 (es) Formulaciones en solucion estables de la hormona foliculoestimulante (fsh) y de variantes de fsh; procedimiento para preparar dichas formulaciones yarticulos de manufactura que comprenden dichas formulaciones
NO179479C (no) Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
ATE311844T1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
DE69433092D1 (de) Getränk mit einem gehalt an alpha-ketoglutarsäure
ES2183332T3 (es) Aminoacidos biciclicos aromaticos.
ES2162051T3 (es) Preparacion dermatologica para tratar queratosis actinicas.
AR003893A1 (es) Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol.
DOP2024000269A (es) Composiciones y uso de la tirzepatida
DE58905235D1 (de) Wasch- und reinigungsmittel.
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
ES2196501T3 (es) Utilizacion de aminoacidos marcados con c13 como agente de diagnostico en la diabetes.
MX172107B (es) Procedimiento para la desinfeccion de masas para vaciado medicinales
AR010924A1 (es) Azapeptidos ciclicos, sus enantiomeros y diastereomeros, un procedimiento para su preparacion, su empleo para preparar un medicamento, las preparacionesfarmaceuticas que los contienen y un procedimiento para obtener estas preparaciones farmaceuticas.
ES2089613T3 (es) Composicion detergente.
JPS5756420A (en) Bath agent
CO4770983A1 (es) Metodo y composicion para el tratamiento de la osteoporosis
JP2526609B2 (ja) 皮膚洗浄剤組成物
ATE219625T1 (de) Verfahren und zusammensetzungen zur behandlung der osteoporose
Quigley et al. Demonstration of calcospherites in mature human dentin